Application Sponsors
ANDA 213162 | TEVA PHARMS USA | |
Marketing Status
None (Tentative Approval) | 001 |
None (Tentative Approval) | 002 |
None (Tentative Approval) | 003 |
Application Products
001 | CAPSULE;ORAL | 100MG | 0 | DROXIDOPA | DROXIDOPA |
002 | CAPSULE;ORAL | 200MG | 0 | DROXIDOPA | DROXIDOPA |
003 | CAPSULE;ORAL | 300MG | 0 | DROXIDOPA | DROXIDOPA |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2020-09-01 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
TEVA PHARMS USA
cder:Array
(
[0] => Array
(
[ApplNo] => 213162
[companyName] => TEVA PHARMS USA
[docInserts] => ["",""]
[products] => [{"drugName":"DROXIDOPA","activeIngredients":"DROXIDOPA","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"09\/01\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-09-01
)
)